REVIEW Procainamide is sodium channel blocker. It stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses thereby effecting local anesthetic action. Procainamide's major active metabolite is N-acetylprocainamide, which is approximately equipotent with the parent drug as an antiarrhythmic agent.
REFERENCES
[1]
Najer, Henry; Joannic, Michel Preparation of mono- and dihydrochloride of 2-diethylaminoethylamide and of 3-diethylaminopropylamide of p-aminobenzoic acid Annales Pharmaceutiques Francaises (1955), 13, 556-9.
[2]
Nakajima, Isao; Tsujikawa, Kouji; Kato, Yukuru; Shinuchi, Tadami 4-Amino-N-(diethylaminoethyl)benzamides Ger. Offen. (1972), DE 2162917 A 19720907.
[3]
Zamponi GW, Sui X, Codding PW, French RJ. Dual actions of procainamide on batrachotoxin-activated sodium channels: open channel block and prevention of inactivation. Biophys J. 1993 Dec;65(6):2324-34.
[4]
Fenster PE, Comess KA, Marsh R, Katzenberg C, Hager WD. Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusion. Am Heart J. 1983 Sep;106(3):501-4.
All products are stocked and shipped from the SF Bay, California, USA via FedEx, UPS or DHL.
All batches backed with full quality assurance.
⚠️
All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.
These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.
Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.